Cuộc họp báo cáo kết quả kinh doanh Quý 3/2026 của Avantor (AVTR): Tăng trưởng tự thân trở lại, nâng dự phóng
Doanh thu quý 3/2026 của Avantor tăng 5,2% về mặt tăng trưởng tự thân nhờ sự tăng trưởng của VWR và BMP. AVTR đã nâng dự báo tăng trưởng tự thân, EPS và dòng tiền tự do cho cả năm.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.